(All fields required)
Please enter a valid email.
Please enter your name.
Pramod P. Reddy, MD Director, Division of Pediatric Urology
is a pediatric urologist studying the molecular regulation of bladder organogenesis using a Xenopus animal model, tissue engineering strategies for bladder substitution/replacement and epigenetic changes in bladder outlet obstruction. He conducts several clinic outcome studies on neurogenic detrusor instability, overactive bladder and the use of catheters in children with neurogenic bladders.
Director, Division of Pediatric Urology
Professor, Division of Pediatric Surgery
Professor, Consultant Pediatric Urologist, Arkansas Children's Hospital
Kidney stones; ESWL; genitourinary surgery; clinical trials
Bladder organogenesis; tissue engineering of bladder matrix
MBBS: Nagarjuna University, Guntur, India 1990.
Residency: Albany Medical Center, Albany, NY.
Fellowship: The Hospital For Sick Children, Toronto, ON, Canada.
Certification: American Board of Urology 2001.
Reddy PP, Defoor WR. Ureteroscopy: The standard of care in the management of upper tract urolithiasis in children. Indian J Urol. 2010 Oct;26(4):555-63.
Ivancić V, Defoor W, Jackson E, Alam S, Minevich E, Reddy P, Sheldon C. Progression of renal insufficiency in children and adolescents with neuropathic bladder is not accelerated by lower urinary tract reconstruction. J Urol. 2010 Oct;184(4 Suppl):1768-74.
DeFoor WR, Jackson E, Minevich E, Caillat A, Reddy P, Sheldon C, Asplin J. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate. Urology. 2010 Jul;76(1):242-5.
Traxel E, DeFoor W, Reddy P, Sheldon C, Minevich E. Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection. J Urol. 2009 Oct;182(4 Suppl):1708-12.
DeFoor WR, Heshmat S, Minevich E, Reddy P, Koyle M, Sheldon C. Long-term outcomes of the neobladder in pediatric continent urinary reconstruction. J Urol. 2009 Jun;181(6):2689-93; discussion 2693-4.
Reddy PP, Borgstein NG, Nijman RJ, Ellsworth PI. Long-term efficacy and safety of tolterodine in children with neurogenic detrusor overactivity. J Pediatr Urol. 2008 Dec;4(6):428-33.
DeFoor W, Clark C, Jackson E, Reddy P, Minevich E, Sheldon C. Risk factors for end stage renal disease in children with posterior urethral valves. J Urol. 2008 Oct;180(4 Suppl):1705-8; discussion 1708.
Heshmat S, DeFoor W, Minevich E, Reddy P, Reeves D, Sheldon C. Use of customized MIC-KEY gastrostomy button for management of MACE stomal complications. Urology. 2008 Nov;72(5):1026-9.
DeFoor W, Minevich E, Jackson E, Reddy P, Clark C, Sheldon C, Asplin J. Urinary metabolic evaluations in solitary and recurrent stone forming children. J Urol. 2008 Jun;179(6):2369-72.
Reddy PP. Recent advances in pediatric uroradiology. Indian J Urol. 2007 Oct;23(4):390-402.
William Robert DeFoor Jr., MD, MPH Director, Clinical Research
is a pediatric urologist conducting a multi-institutional clinical trial to assess outcomes in vesico-ureteral reflux. Other studies include outcomes in neurogenic bladder (NGB), urinary biomarkers in ureteropelvic junction obstruction, complications of clean intermittent catheterization, urinary metabolic evaluations in bariatric patients, and UTI prevention with gentamicin bladder irrigations.
Director, Clinical Research
Associate Professor, UC Department of Surgery
Complex genitourinary reconstruction; clinical outcomes research; clinical trials; urolithiasis; uro-oncology; laparoscopic-assisted; robotic-assisted surgery; vesicoureteral reflux
Modulation of apoptosis in cryptorchidism (undescended testes) with anti-oxidant pharmacotherapy; pediatric urologic surgical outcomes analysis using an evidence based medicine approach
BS: Georgia Institute of Technology, Atlanta, GA, 1991.
Fulbright Fellowship: Universite' Rene' Descartes, Paris, France, 1992.
MD: University of Kentucky, Lexington, KY, 1996.
Residency: Medical University of South Carolina, Charleston, SC, 2001.
Fellowship: Cincinnati Children's Hospital, Cincinnati, OH, 2003.
MPH: Harvard University, Boston, Massachusetts, School of Public Health, 2005.
DeFoor, WR, et al. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate. Urology. 2010 Jul;76(1):242-5. DeFoor WR, et al. Long-Term Outcomes of the Neobladder in Pediatric Continent Urinary Reconstruction. J Urol. 2009;181:2689-94.
Traxel E, DeFoor WR, et al. Multivariate analysis of risk factors for urinary tract infections after endoscopic injection of dextranomer-hyaluronic acid. J Urol. 2009;182 (4 Suppl): 1708-12.
DeFoor WR, Tobias N. Simple behavioral modification may be effective first-line treatment in resolution of nocturnal enuresis. J Pediatrics. 2009;155(5):760.
Heshmat S, DeFoor WR, et al. The use of customized Mic-Key gastrostomy button for the management of the MACE stomal complications. Urology. 2008;72(5):1026-9.
DeFoor WR, et al. Urinary metabolic evaluations in solitary and recurrent stone forming children. J Urol. 2008;179(6):2369-72.
DeFoor WR, et al. Risk factors for end stage renal disease in children with posterior urethral valves. J Urol. 2008;180(4 Suppl):1705-8; discussion 1708.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2013 Cincinnati Children's Hospital Medical Center